A Tale of Two Factors: What determines rate of progression in Huntington Disease? A Longitudinal MRI study

Por Rosas, H. Diana, Reuter, Martin, Doros, Gheorghe, Lee, Stephanie Y., Triggs, Tyler, Malarick, Keith, Fischl, Bruce, Salat, David H., Hersch, Steven M.
Publicado em 2011

PRECREST: A phase II prevention and biomarker trial of creatine in at-risk Huntington disease

Por Rosas, Herminia D., Doros, Gheorghe, Gevorkian, Sona, Malarick, Keith, Reuter, Martin, Coutu, Jean-Philippe, Triggs, Tyler D., Wilkens, Paul J., Matson, Wayne, Salat, David H., Hersch, Steven M.
Publicado em 2014